Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
about
Subcortical volumetric abnormalities in bipolar disorderA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsManagement of bipolar depression with lamotrigine: an antiepileptic mood stabilizerBrain Structural Effects of Psychopharmacological Treatment in Bipolar DisorderCell atrophy and loss in depression: reversal by antidepressant treatmentCellular plasticity cascades in the pathophysiology and treatment of bipolar disorderTrehalose induced antidepressant-like effects and autophagy enhancement in miceSynergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionValproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylationThe effectiveness of anticonvulsants in psychiatric disordersElevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study.DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders.Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.Posterior cerebellar vermal deficits in bipolar disorder.Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons.Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder.The inhibition kinetics of yeast glutathione reductase by some metal ions.Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathwayPreclinical Evidences for an Antimanic Effect of Carvedilol.Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorderIn search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brainLithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorderProgress in neuroprotective strategies for preventing epilepsy.Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium.Early intervention in bipolar disorder, part II: therapeuticsChronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex.Bipolar disorder: from genes to behavior pathwaysTarget identification for CNS diseases by transcriptional profiling.Glucocorticoid receptors modulate mitochondrial function: A novel mechanism for neuroprotectionFrequency of and rationales for the combined use of electroconvulsive therapy and antiepileptic drugs in Austria and the literature.Anti-depressant-like effect of peony: a mini-review.DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders.The relationship between oxidative stress and post-translational modification of the dopamine transporter in bipolar disorder.Staging and neuroprogression in bipolar disorder.Anaesthesia for positron emission tomography scanning of animal brains.Challenges in drug target discovery in bipolar disorder.Novel routes to bipolar disorder drug discovery.
P2860
Q23747500-E9F0E815-891C-47FE-9949-F2802FAA6E05Q26741164-25A49C18-0704-4D5E-9120-384E8493C1A8Q26777966-DA7B2F16-6DD5-4BAF-9D25-59CC99A1D776Q26786245-E189C801-2413-4A7A-884D-F0A9C6F967E7Q27013609-07E85195-7DC0-4040-BDCC-5DADB2C211B8Q28251880-1355CFA1-96D4-4844-93E7-AAA37507520AQ28290140-776FDCB5-66A4-49EF-AE77-3A8D20C1FDADQ28468536-A35A4273-E927-4BF6-8FE0-12F3DD8CF811Q28572236-89A24B11-EF28-4204-9DBF-56A83F7B304CQ28744504-DB6A0DE2-21CA-4DD0-8776-8D9D3D400986Q30488395-EBD62A4D-9BE4-4011-A958-7E42D4D3FBCBQ33618952-BDDD6F65-4D7D-4111-8EDE-3C4A2372E10DQ33727970-DA840DF5-6E68-406D-9796-386F50AADAFEQ33872654-3EEE667F-494B-48EB-9757-F1CE455E8289Q33904292-36E7A3B9-A921-4D43-8507-00381072C004Q34151554-5A77B596-098E-46A7-9364-F9E129F977AFQ34421875-6821DB3C-90BC-4D89-A7C6-EB2715A19F5AQ34548121-CA9B4C9D-9701-4A6B-A70B-962FF6E4BD77Q34685818-084A19FF-2554-4A39-9E64-32AACFFDE34AQ35546227-B947E1C3-947D-491D-88CB-1A612E5C026DQ35657017-A2EAB491-265D-43CA-895C-175540AA6A74Q35661134-C6C37977-1FBA-422A-97DC-ACE940E9755FQ35943834-33D33709-8CB8-4003-9D39-DFCB0B2F7AF3Q36253556-424FCEAB-705F-4D8F-A679-4E7BEB704919Q36480123-09DE3440-BD43-425D-8781-79D5260B4131Q36739694-7111CF46-3A15-47C4-9CB0-EBDA497638EAQ36873015-C6D7B340-0298-47B8-B609-0321325F9862Q37071007-6C45CD54-ADE5-4FA1-8A00-6FD6DF2EB885Q37088689-367E1F06-6991-4CAB-9C7E-80A668D0A8BFQ37143399-738C859D-8179-4B77-A2EE-271E148A33CDQ37175279-FBCEC8B3-4285-4580-AF36-791449B4BE6CQ37324047-E5C38F25-9B45-48AA-84E4-FEA4D2FB2E75Q37648736-5542A033-B400-4A48-B018-D3C428DBD78FQ37971138-DD31F69C-D01A-4DEF-967C-AB6992330D72Q37998459-A3E70F4E-9491-4D6E-A474-2BE2BBAE256DQ38031289-E86D8110-F771-4B1A-A6F2-B44F5FF77DEFQ38054585-906B952F-B8D1-4B5E-90FB-A31E2F1DC945Q38076701-1DC054C2-8673-431D-BBB6-867FD4ECDFE5Q38082552-4D1DD333-899C-40BA-B0D4-84F12227AC35Q38109244-3E708551-7918-4648-9B66-CC64224F4696
P2860
Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@ast
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@en
type
label
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@ast
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@en
prefLabel
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@ast
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@en
P2093
P356
P1476
Mood stabilizers target cellul ...... lopment of novel therapeutics.
@en
P2093
Husseini K Manji
Robert J Schloesser
Rosilla F Bachmann
Todd D Gould
P2888
P304
P356
10.1385/MN:32:2:173
P577
2005-10-01T00:00:00Z
P5875
P6179
1016649818